111 related articles for article (PubMed ID: 9835918)
1. Brief report. CD19/CD5 acute lymphoblastic leukemia.
Subirá D; Roman A; Jiménez-Garófano C; Prieto E; Martínez-Delgado B; Aceituno E; García R; Outeiriño J
Med Pediatr Oncol; 1998 Dec; 31(6):551-2. PubMed ID: 9835918
[No Abstract] [Full Text] [Related]
2. CD5 positive B-ALL, a uniquely aggressive subcategory of B-ALL? A case report and brief review of the literature.
Staley EM; Feldman AZ; Koenig RG; Hill B
Pediatr Blood Cancer; 2019 Jan; 66(1):e27484. PubMed ID: 30270496
[TBL] [Abstract][Full Text] [Related]
3. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
[TBL] [Abstract][Full Text] [Related]
4. B-Lymphoblastic Leukemia With Aberrant CD5 Expression.
Ye MT; Zhu J; Luo DX; Wang Y; Chen Z; Yang Y; Tian C; Zhang Y; You MJ
Am J Clin Pathol; 2021 Sep; 156(4):586-595. PubMed ID: 33822875
[TBL] [Abstract][Full Text] [Related]
5. IL-10 is predominantly produced by CD19(low)CD5(+) regulatory B cell subpopulation: characterisation of CD19 (high) and CD19(low) subpopulations of CD5(+) B cells.
Lee JH; Noh J; Noh G; Choi WS; Lee SS
Yonsei Med J; 2011 Sep; 52(5):851-5. PubMed ID: 21786452
[TBL] [Abstract][Full Text] [Related]
6. T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts.
Feucht J; Kayser S; Gorodezki D; Hamieh M; Döring M; Blaeschke F; Schlegel P; Bösmüller H; Quintanilla-Fend L; Ebinger M; Lang P; Handgretinger R; Feuchtinger T
Oncotarget; 2016 Nov; 7(47):76902-76919. PubMed ID: 27708227
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
Raponi S; De Propris MS; Intoppa S; Milani ML; Vitale A; Elia L; Perbellini O; Pizzolo G; Foá R; Guarini A
Leuk Lymphoma; 2011 Jun; 52(6):1098-107. PubMed ID: 21348573
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.
Chopra A; Bakhshi S; Pramanik SK; Pandey RM; Singh S; Gajendra S; Gogia A; Chandramohan J; Sharma A; Kumar L; Seth R; Rai S; Kumar R
Eur J Haematol; 2014 Mar; 92(3):211-8. PubMed ID: 24329989
[TBL] [Abstract][Full Text] [Related]
10. Molecular assessment of clonality in a pre-B ALL unusually relapsing as a mature-B ALL.
Balduzzi A; Corral L; Gaipa G; Germano G; Giudici G; Cantu'-Rajnoldi A; Biondi A
Leukemia; 1999 Dec; 13(12):2114-6. PubMed ID: 10602438
[No Abstract] [Full Text] [Related]
11. CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study.
Wei G; Hu Y; Pu C; Yu J; Luo Y; Shi J; Cui Q; Wu W; Wang J; Xiao L; Wu Z; Huang H
Ann Hematol; 2018 May; 97(5):781-789. PubMed ID: 29417201
[TBL] [Abstract][Full Text] [Related]
12. Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia.
Piccaluga PP; Arpinati M; Candoni A; Laterza C; Paolini S; Gazzola A; Sabattini E; Visani G; Pileri SA
Leuk Lymphoma; 2011 Feb; 52(2):325-7. PubMed ID: 21077738
[No Abstract] [Full Text] [Related]
13. The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural killer cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult patients.
Kellner C; Zhukovsky EA; Pötzke A; Brüggemann M; Schrauder A; Schrappe M; Kneba M; Repp R; Humpe A; Gramatzki M; Peipp M
Leukemia; 2013 Jul; 27(7):1595-8. PubMed ID: 23277329
[No Abstract] [Full Text] [Related]
14. [Treatment of lymphoblastic leukemia with CD19-specific modified chimeric antigen receptor T cells].
Li HH; Zhu P; Wu XQ; Liu YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1753-6. PubMed ID: 25543510
[TBL] [Abstract][Full Text] [Related]
15. [CD5+, CD7+, and CD19+ non-Hodgkin's lymphoma in a child].
Toyoda Y; Horikoshi Y; Tonouchi T; Mimaya J; Hamazaki M; Taniguchi S; Kawai S; Kawa-ha K; Yumura K; Kaneko Y
Rinsho Ketsueki; 1991 Feb; 32(2):137-41. PubMed ID: 1709216
[TBL] [Abstract][Full Text] [Related]
16. [The expression of CD19 in 210 cases of childhood acute leukemia and its significance].
Chen YH; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Qian BQ; Xu WQ; Ning BT
Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):188-91. PubMed ID: 15144712
[TBL] [Abstract][Full Text] [Related]
17. Eradication of CD19+ leukemia by targeted calicheamicin θ.
Bernt KM; Prokop A; Huebener N; Gaedicke G; Wrasidlo W; Lode HN
Bioconjug Chem; 2009 Aug; 20(8):1587-94. PubMed ID: 19572629
[TBL] [Abstract][Full Text] [Related]
18. Expression Level of Membrane Markers CD5, CD19, and CD20 in B Cells after UV-Irradiation and Incubation in the Presence of Autologous Plasma.
Zemchenkova OV; Basharina OV; Artyukhov VG
Bull Exp Biol Med; 2021 May; 171(2):222-225. PubMed ID: 34173108
[TBL] [Abstract][Full Text] [Related]
19. Blinatumomab-induced donor T-cell activation for post-stem cell transplant-relapsed acute CD19-positive biphenotypic leukemia.
Alcharakh M; Yun S; Dong Y; Vincelette ND; Daud M; Manzoor S; Riaz IB; Anwer F
Immunotherapy; 2016 Jul; 8(8):847-52. PubMed ID: 27381683
[TBL] [Abstract][Full Text] [Related]
20. Blinatumomab: a novel agent to treat minimal residual disease in patients with acute lymphoblastic leukemia.
Advani AS
Clin Adv Hematol Oncol; 2011 Oct; 9(10):776-7. PubMed ID: 22252580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
